Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation [2]

1. Lopez-Jimenez, J.
2. De las Heras, E.
3. Hilara, Y.
4. Garcia-Larana, J.
5. Perez-Oteyza, J.
6. Bellas, C.
7. Munoz, A.
8. Rocamora, A.
9. Nunez, M.
10. Odriozola, J.